EDGAR Filing Documents for 0001193125-15-372802

Form 8-K - Current report:

SEC Accession No. 0001193125-15-372802

Filing Date

2015-11-10

Accepted

2015-11-10 08:31:01

Documents

Period of Report

2015-11-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d30180d8k.htm	8-K	17475
2	EX-10.1	d30180dex101.htm	EX-10.1	438592
3	GRAPHIC	g30180dsp066.jpg	GRAPHIC	61710
4	GRAPHIC	g30180dsp067.jpg	GRAPHIC	90702
5	GRAPHIC	g30180dsp077.jpg	GRAPHIC	144125
	Complete submission text file	0001193125-15-372802.txt		866072

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037

Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500

LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)